The overexpression of MUC1 has been reported to limit the effectiveness of fluorouracil (5-FU) by reducing intracellular drug uptake and anti-tumor drug action in pancreatic tumors [50]. This evidence concerns the gene MUC1 and pancreatic neoplasm.